Department of Pharmacology, Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.
Department of Pharmacology, SPP School of Pharmacy & Technology Management, NMIMS University, Mumbai, India.
Nutr Neurosci. 2022 May;25(5):920-930. doi: 10.1080/1028415X.2020.1821518. Epub 2020 Sep 23.
Ischemic stroke is one of the leading causes of disability in adults worldwide. The present study was aimed to evaluate the efficacy of Narirutin-rich fraction (NRF), obtained from grape fruit peel, on cerebral ischemia/reperfusion injury in rats. Male Wistar rats (180-200 g) were subjected to bilateral carotid artery occlusion for 30 min followed by reperfusion for 24 h to induce cerebral ischemia/reperfusion injury. NRF (150, 300 mg/kg, oral) was administered for 7 days continuously before animals were subjected to ischemia/reperfusion injury. Various behavioral tests (for measurement of motor coordination, locomotor activity, and spatial memory), biochemical parameters (lipid peroxidation, superoxide dismutase, and catalase activity), and histopathological alterations were assessed. Seven-day NRF (150 and 300 mg/kg) pretreatment significantly improved neurobehavioral alterations and histological findings as compared to the disease control group. Further NRF treatment significantly reduced oxidative damage as indicated by improved lipid peroxidation, superoxide dismutase, and catalase activity as compared to disease control animals. The present study demonstrated the protective effect of NRF against cerebral ischemia/reperfusion injury in rats. The results suggest that NRF can be a potential pretreatment option against cerebral ischemia/reperfusion injury.
缺血性脑卒中是全球成年人致残的主要原因之一。本研究旨在评估从葡萄柚皮中提取的柚皮苷丰富部分(NRF)对大鼠脑缺血/再灌注损伤的疗效。雄性 Wistar 大鼠(180-200g)进行双侧颈总动脉闭塞 30min 后再灌注 24h,诱导脑缺血/再灌注损伤。NRF(150、300mg/kg,口服)在动物进行缺血/再灌注损伤前连续给药 7 天。评估了各种行为测试(用于测量运动协调、运动活性和空间记忆)、生化参数(脂质过氧化、超氧化物歧化酶和过氧化氢酶活性)和组织病理学改变。与疾病对照组相比,7 天 NRF(150 和 300mg/kg)预处理显著改善了神经行为改变和组织学发现。与疾病对照组动物相比,NRF 治疗还显著降低了氧化损伤,表现为脂质过氧化、超氧化物歧化酶和过氧化氢酶活性的改善。本研究证明了 NRF 对大鼠脑缺血/再灌注损伤的保护作用。结果表明,NRF 可能是一种针对脑缺血/再灌注损伤的潜在预处理选择。